PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Topical galbanum oil combined with dry cupping significantly increased blood oxygen saturation (SpO2) compared to standard therapy alone (p<0.001) [PMID:37663385].
F. galbaniflua demonstrated antioxidant and antimicrobial properties in rat models, supporting its use for skin inflammation and wound healing [PMID:40934469].
Galbanum (Ferula galbaniflua) was identified as one of the most potent plant extracts for tumoricidal activity in vitro [PMID:20564497].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 33458896 (2021) — Metabolic differences of two Ferula species as potential sources of galbanum: An NMR-based metabolomics study. · Phytochemical analysis : PCA
- 2.PMID: 37663385 (2023) — Efficacy of topical galbanum oil with dry cupping in hospitalized COVID-19 patients: A randomized open-label clinical trial. · Avicenna journal of phytomedicine
- 3.PMID: 28687892 (2017) — Transcriptome and metabolome analysis of Ferula gummosa Boiss. to reveal major biosynthetic pathways of galbanum compounds. · Functional & integrative genomics
- 4.PMID: 38729496 (2024) — A comprehensive review of the molecular and genetic mechanisms underlying gum and resin synthesis in Ferula species. · International journal of biological macromolecules
- 5.PMID: 37515666 (2023) — Encapsulation of probiotic Lactobacillus acidophilus ATCC 4356 in alginate-galbanum (Ferula Gummosa Boiss) gum microspheres and evaluation of the survival in simulated gastrointestinal conditions in probiotic Tahini halva.